Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.46 |
| ▸ | IAPP | P10997 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | DAO | P14920 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | CTSG | P08311 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28318473 | 0.92 | ALOX5 (0.53) | ALOX5PTGS2GABRA1GABRB2 | |
| SCHEMBL2150980 | 0.82 | MPO (0.50) | TSHRIDO1 | |
| SCHEMBL15184061 | 0.78 | TSHR (0.39) | ALOX5PTGS2TSHRIDO1DAO | |
| SCHEMBL22991758 | 0.78 | IAPP (0.55) | ALOX5PTGS2IAPPALDH1A1 | |
| SCHEMBL2806496 | 0.78 | CYP4F2 (0.50) | ALOX5PTGS2TSHRALDH1A1 | |
| SCHEMBL9749140 | 0.77 | — | — | |
| SCHEMBL30529905 | 0.76 | ESR1 (0.38) | ALOX5PTGS2ALDH1A1 | |
| SCHEMBL30368095 | 0.76 | MPO (0.49) | IDO1 | |
| SCHEMBL201764 | 0.76 | ALOX5 (0.61) | ALOX5PTGS2GABRA1GABRB2IAPP | |
| SCHEMBL8819214 | 0.75 | TAAR1 (0.52) | ALOX5PTGS2TSHRDAOALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110312698-A | Between producing high-purity, bis- (4- alkylphenol) derivatives of m- coupling and application thereof | 鲁汶天主教大学 | 2019-10-08 | — | — | CN | disclosed |
| US-9783474-B2 | Catalytic biomass conversion methods, catalysts, and methods of making the same | PURDUE RESEARCH FOUNDATION (US) | 2017-10-10 | — | — | US | disclosed |
| US-20160289150-A1 | CATALYTIC BIOMASS CONVERSION METHODS, CATALYSTS, AND METHODS OF MAKING THE SAME | PURDUE RESEARCH FOUNDATION (US) | 2016-10-06 | — | — | US | disclosed |
| EP-3060718-A1 | CATALYTIC BIOMASS CONVERSION METHODS, CATALYSTS, AND METHODS OF MAKING THE SAME | Purdue Research Foundation (US) | 2016-08-31 | — | — | EP | disclosed |
| WO-2015061802-A1 | CATALYTIC BIOMASS CONVERSION METHODS, CATALYSTS, AND METHODS OF MAKING THE SAME | PURDUE RESEARCH FOUNDATION (US) | 2015-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289150-A1 | CATALYTIC BIOMASS CONVERSION METHODS, CATALYSTS, AND METHODS OF MAKING THE SAME | HAO2, HPD, HAAO | ALOX5 80/4885PTGS2 873/4885GABRA1 2020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.